Veracyte Inc (VCYT) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

Veracyte Inc (Veracyte) is a molecular diagnostics company that uses genomic technology to resolve diagnostic ambiguity. The companys pipeline products include Afirma thyroid FNA analysis for the diagnosis of thyroid cancer based on its proprietary afirma gene expression classifier. It also provides percepta bronchial genomic classifier an assay to evaluate patients with lung nodules that are suspected for cancer. Veracyte provides genomic testing to other areas of substantial clinical need with diagnostic ambiguity. The company markets its afirma solutions through its sales force across in the US. It also commercializes its products in Brazil. Veracyte is headquartered in South San Francisco, California, the US.

Veracyte Inc (VCYT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.



List of Tables 4
List of Figures 4
Veracyte Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Veracyte Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Veracyte Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Veracyte Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Veracyte Inc, Medical Devices Deals, 2012 to YTD 2018 9
Veracyte Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Veracyte Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Veracyte Secures USD14.95 Million in Venture Funding 11
Partnerships 12
Veracyte Enters into Research Agreement with Loxo Oncology 12
Equity Offering 13
Veracyte Raises USD40 Million in Private Placement of Shares 13
Veracyte Completes IPO For US$65 Million 15
Veracyte Inc - Key Competitors 16
Veracyte Inc - Key Employees 17
Veracyte Inc - Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
May 01, 2018: Veracyte Reports First Quarter 2018 Financial Results 19
Feb 27, 2018: Veracyte Announces Fourth Quarter and Full-Year 2017 Financial Results 20
Nov 06, 2017: Veracyte Announces Third Quarter 2017 Financial Results 22
Jul 31, 2017: Veracyte Announces Second Quarter 2017 Financial Results 24
May 03, 2017: Veracyte Announces First Quarter 2017 Financial Results 25
Mar 01, 2017: Veracyte Announces Fourth Quarter and Full-Year 2016 Financial Results, Provides 2017 Financial Outlook 26
Corporate Communications 27
Feb 28, 2017: Veracyte Announces Executive Promotions 27
Other Significant Developments 28
Jan 08, 2018: Veracyte Announces Strategic Realignment And New Appointments To Advance Commercial Growth 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List Of Tables

List of Tables
Veracyte Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Veracyte Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Veracyte Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Veracyte Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Veracyte Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Veracyte Inc, Medical Devices Deals, 2012 to YTD 2018 9
Veracyte Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Veracyte Secures USD14.95 Million in Venture Funding 11
Veracyte Enters into Research Agreement with Loxo Oncology 12
Veracyte Raises USD40 Million in Private Placement of Shares 13
Veracyte Completes IPO For US$65 Million 15
Veracyte Inc, Key Competitors 16
Veracyte Inc, Key Employees 17
Veracyte Inc, Other Locations 18
Veracyte Inc, Subsidiaries 18

List Of Figures

List of Figures
Veracyte Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Veracyte Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Veracyte Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Veracyte Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Veracyte Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Veracyte Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Veracyte Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Veracyte Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Veracyte Inc, Medical Devices Deals, 2012 to YTD 2018 9

Veracyte Inc (VCYT) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Veracyte Inc (Veracyte) is a molecular diagnostics company that uses genomic technology to resolve diagnostic ambiguity. The companys pipeline products include Afirma thyroid FNA analysis for the diagnosis of thyroid

USD 250 View Report

Veracyte Inc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Veracyte Inc Company Profile is a detailed strategic and analytical report on Veracyte Inc. The 2018 version of the report offers detailed insights into the companys strategies, developments, outlook and

USD 200 View Report

Veracyte Inc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Veracyte Inc Company Profile is a detailed strategic and analytical report on Veracyte Inc. The 2018 version of the report offers detailed insights into the companys strategies, developments, outlook and

USD 200 View Report

Veracyte Inc (VCYT) - Medical Equipment - Deals and Alliances Profile.

Veracyte Inc (Veracyte) is a molecular diagnostics company that uses genomic technology to resolve diagnostic ambiguity. The companys pipeline products include Afirma thyroid FNA analysis for the diagnosis of thyroid

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available